Moreover, the addition of an anti-IL-13 blocking antibody abrogated the development of SW1116 colonies, confirming the involvement of IL-13 in the ILC2-PPARγ dependent effect on CRC cells (Fig. 5f). This evidence concerns the gene IL13 and colorectal carcinoma.